{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:11:13Z","timestamp":1790637073331,"version":"4.1.0"},"reference-count":26,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.3892\/ol.2015.3545","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T06:35:01Z","timestamp":1438151701000},"page":"2192-2196","source":"Crossref","is-referenced-by-count":27,"title":["Bortezomib attenuates HIF-1- but not HIF-2-mediated transcriptional activation"],"prefix":"10.3892","volume":"10","author":[{"given":"NORAINI","family":"ABD-AZIZ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ERIC J.","family":"STANBRIDGE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NORAZIZAH","family":"SHAFEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,7,29]]},"reference":[{"key":"key20180108100410_b1-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.med.57.042905.122625","article-title":"Bortezomib: Proteasome inhibition as an effective anticancer therapy","volume":"57","author":"Richardson","year":"2006","journal-title":"Annu Rev Med"},{"key":"key20180108100410_b2-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/0008-5472.CAN-05-1195","article-title":"Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells","volume":"66","author":"Roccaro","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108100410_b3-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the first proteasome inhibitor anticancer drug: Current status and future perspectives","volume":"11","author":"Chen","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180108100410_b4-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1128\/MCB.00552-06","article-title":"Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain","volume":"26","author":"Kaluz","year":"2006","journal-title":"Mol Cell Biol"},{"key":"key20180108100410_b5-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood-2007-11-120576","article-title":"Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1","volume":"111","author":"Shin","year":"2008","journal-title":"Blood"},{"key":"key20180108100410_b6-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9440(10)64554-3","article-title":"The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers and tumor-associated macrophages","volume":"157","author":"Talks","year":"2000","journal-title":"Am J Pathol"},{"key":"key20180108100410_b7-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.11.1.72","article-title":"Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells","volume":"11","author":"Tian","year":"1997","journal-title":"Genes Dev"},{"key":"key20180108100410_b8-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","article-title":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"key20180108100410_b9-ol-0-0-3545","first-page":"162","article-title":"Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?","volume":"1795","author":"Kaluz","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"key20180108100410_b10-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1091\/mbc.E06-05-0419","article-title":"The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha","volume":"18","author":"Hu","year":"2007","journal-title":"Mol Biol Cell"},{"key":"key20180108100410_b11-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"25703","DOI":"10.1074\/jbc.M602329200","article-title":"Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development","volume":"281","author":"Yoon","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180108100410_b12-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1126\/science.1169956","article-title":"Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1","volume":"324","author":"Dioum","year":"2009","journal-title":"Science"},{"key":"key20180108100410_b13-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccr.2006.08.026","article-title":"Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype","volume":"10","author":"HolmquistMengelbier","year":"2006","journal-title":"Cancer Cell"},{"key":"key20180108100410_b14-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1158\/0008-5472.CAN-06-2722","article-title":"Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors","volume":"67","author":"Birle","year":"2007","journal-title":"Cancer Res"},{"key":"key20180108100410_b15-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1074\/jbc.274.10.6519","article-title":"Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway","volume":"274","author":"Kallio","year":"1999","journal-title":"J Biol Chem"},{"key":"key20180108100410_b16-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1089\/jir.2012.0095","article-title":"The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: The interplay between VHL and interferon-\u03b2 signaling","volume":"33","author":"Ch'ng","year":"2013","journal-title":"J Interferon Cytokine Res"},{"key":"key20180108100410_b17-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/carcin\/bgl143","article-title":"Renal cancer cells lacking hypoxia-inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha","volume":"28","author":"Shinojima","year":"2007","journal-title":"Carcinogenesis"},{"key":"key20180108100410_b18-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/01.ASN.0000059308.82322.4F","article-title":"Podocyte expression of hypoxia-inducible factor (HIF)-1 and HIF-2 during glomerular development","volume":"14","author":"Freeburg","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"key20180108100410_b19-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00277-007-0359-6","article-title":"Contribution of HIF-1alpha or HIF-2alpha to erythropoietin expression: In vivo evidence based on chromatin immunoprecipitation","volume":"87","author":"Yeo","year":"2008","journal-title":"Ann Hematol"},{"key":"key20180108100410_b20-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbrc.2008.03.147","article-title":"Rational design of minimal hypoxia-inducible enhancers","volume":"370","author":"Kaluz","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108100410_b21-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1073\/pnas.94.9.4273","article-title":"A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development","volume":"94","author":"Ema","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20180108100410_b22-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1158\/0008-5472.CAN-05-2519","article-title":"Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: Implications for targeting the HIF pathway","volume":"66","author":"Carroll","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108100410_b23-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1172\/JCI31750","article-title":"HIF-1 and HIF-2: Working alone or together in hypoxia?","volume":"117","author":"Ratcliffe","year":"2007","journal-title":"J Clin Invest"},{"key":"key20180108100410_b24-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02797460","article-title":"In vitro cultivation of human renal cell cancer. I. Establishment of cells in culture","volume":"12","author":"Williams","year":"1976","journal-title":"Vitro"},{"key":"key20180108100410_b25-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1\u03b1 and HIF2\u03b1: Sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20180108100410_b26-ol-0-0-3545","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.1236966","article-title":"Biochemistry. How HIF-1\u03b1 handles stress","volume":"339","author":"Huang","year":"2013","journal-title":"Science"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3545\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T17:09:04Z","timestamp":1567012144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,29]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,7,29]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.3892\/ol.2015.3545"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3545","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,29]]}}}